Work

Immune Checkpoint Inhibitor‐Induced Diabetic Ketoacidosis in a Patient With Pre‐Existing Type 2 Diabetes: A Case Report

Year: 2026

Type: article

Abstract: Immune checkpoint inhibitors (ICIs) may cause rare life-threatening ICI-associated diabetes mellitus. We report a 60-year-old Chinese male with pre-existing type 2 diabetes who developed toripalimab-induced diabetic ketoacidosis after 3 treatment cycles. He also had toripalimab-related hyperthyroidism. Clinicians should closely monitor plasma glucose during and after ICI therapy.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.73834

Authors: Lingfen Zeng, Jieming Sun

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,820

OpenAlex ID: W7225245896

FWCI:

Cites: 4

Cited by:

Related to: 10